Results 41 to 50 of about 9,121 (212)

Comparison of OS, ORR and DCR between the non-CIK and CIK groups.

open access: yes, 2014
Forest plot comparing the 1-, 2- and 3-year OS between the non-CIK and CIK groups.OR, odds ratio; OS, overall survival. Due to the low heterogeneity detected, the fixed-effect model was used in this OS meta-analysis.
Jin-Long Liu (628994)   +10 more
core   +1 more source

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

open access: yesExperimental Hematology & Oncology, 2012
Purpose To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. Materials and methods Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a
Ma Yue   +5 more
doaj   +1 more source

Comparison of phenotype between CIK and DC-CIK cells on day28.

open access: yes, 2014
Compared with CIK cells, NKT cells were significantly increased in DC-CIK cells. However, there was no significant difference in the expression of CD3+, CD4+, CD8+ T cells and NK cells between CIK cells and DC-CIK cells.
Huiping Wang (436545)   +7 more
core   +1 more source

Applications of Biomaterials in Separators for Secondary Batteries

open access: yesCarbon Energy, EarlyView.
In this review, biomaterial‐based separators are reviewed as sustainable alternatives to conventional polyolefin‐based separators. For 12 different natural polymers, spanning from Protista, Plantae, and Animalia, viable strategies for synthesizing biomass‐based separators are described.
Jongyoung Choi   +3 more
wiley   +1 more source

CD3+CD56+ T cells on CIK cells.

open access: yes, 2023
CD56 was major expressed on CD3+CD8+ T cells in CIK cells (N = 5). (TIF)
Ching-Hsun Hu (14328999)   +6 more
core   +1 more source

HPV Genotype Distribution in Cervical Cancer and High‐Grade Lesions in Norway, and Early Vaccine Impact

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold   +13 more
wiley   +1 more source

Comparison of IL-35 and IL-35R mRNA expression between CIK and DC-CIK cells.

open access: yes, 2014
Compared with CIK cells, (A and B) EBI3 and p35 mRNA expression was significantly decreased in DC-CIK cells, (C and D) gp130 and IL-12Rβ2 mRNA expression was significantly decreased in DC-CIK cells.
Huiping Wang (436545)   +7 more
core   +1 more source

STRATEGI KOMUNIKASI PEMBANGUNAN UPT. PASAR CIK PUAN KOTA PEKANBARU DALAM MEMPERTAHANKAN EKSISTENSI PASAR TRADISIONAL [PDF]

open access: yes, 2023
The presence of modern markets is considered by various groups to have cornered the existence of traditional markets. This type of market is a market where merchandise is traded at the right price so there is no bargaining activity.
yochi, dede, Arif, Muhammad
core   +1 more source

Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model. [PDF]

open access: yesPLoS ONE, 2012
Both adoptive immunotherapy and gene therapy hold a great promise for treatment of malignancies. However, these strategies exhibit limited anti-tumor activity, when they are used alone.
Zhi Yang   +12 more
doaj   +1 more source

U.S. Multinational Corporations’ Initial Income‐Shifting Response to the TCJA

open access: yesJournal of Corporate Accounting &Finance, EarlyView.
ABSTRACT I find U.S. multinational corporations (MNCs) responded to the Tax Cuts and Jobs Act (TCJA) of 2017 by increasing income shifted to foreign sources in the first two years following the effective date. Financially constrained MNCs increased income shifting more, while higher operational uncertainty MNCs increased income shifting less than other
Tyler P. Johnson
wiley   +1 more source

Home - About - Disclaimer - Privacy